Budka, J.; Debowski, D.; Mai, S.; Narajczyk, M.; Hac, S.; Rolka, K.; Vrettos, E.I.; Tzakos, A.G.; Inkielewicz-Stepniak, I.
Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2024, 16, 283.
https://doi.org/10.3390/pharmaceutics16020283
AMA Style
Budka J, Debowski D, Mai S, Narajczyk M, Hac S, Rolka K, Vrettos EI, Tzakos AG, Inkielewicz-Stepniak I.
Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics. 2024; 16(2):283.
https://doi.org/10.3390/pharmaceutics16020283
Chicago/Turabian Style
Budka, Justyna, Dawid Debowski, Shaoshan Mai, Magdalena Narajczyk, Stanislaw Hac, Krzysztof Rolka, Eirinaios I. Vrettos, Andreas G. Tzakos, and Iwona Inkielewicz-Stepniak.
2024. "Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma" Pharmaceutics 16, no. 2: 283.
https://doi.org/10.3390/pharmaceutics16020283
APA Style
Budka, J., Debowski, D., Mai, S., Narajczyk, M., Hac, S., Rolka, K., Vrettos, E. I., Tzakos, A. G., & Inkielewicz-Stepniak, I.
(2024). Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics, 16(2), 283.
https://doi.org/10.3390/pharmaceutics16020283